NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Enfusion, Inc. (NYSE: ENFN)’s sale to Clearwater Analytics for $5.85 per share in cash and $5.40 per share in Clearwater Class A Common Stock. If you are an Enfusion shareholder, click here to learn more about your rights and options. Edible Garden AG Incorpo ...

NEW YORK, Jan. 13, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Enfusion, Inc. (NYSE: ENFN) and its board of directors concerning the proposed acquisition of the company by Clearwater Analytics (NYSE: CWAN). Stockholders will receive a mix of shares of Clearwater Analytics common stock and cash worth $11.25 for each share of Enfusion stock that they hold. The transaction is valued at approximately $1.5 billion and is expected to close in the second quarter of ...

NEW YORK, Jan. 13, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Enfusion, Inc. (NYSE: ENFN), relating to the proposed merger with Clearwater Analytics. Under the terms of the agreement, Enfusion shareholders will receive $5.85 per share in cash and $5.40 ...

I wrote about Enfusion (NYSE: ENFN ) previously ( in August ) with a buy rating as management showed promising execution in its effort to move upmarket, and that growth should recover when theI am an individual investor that is now fully focus on managing my own capital that I have saved up over the years. My investing background spreads across a wide spectrum as I believe there are merits to each approach, for instance: Fundamental investing [Bottoms-up etc.], Technical investing [historical charts analysi ...

Table of Contents ENFN New York Stock Exchange UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40949 Enfusion, Inc. (Exact name of registrant as specified in its charter) ...

Financial Data and Key Metrics Changes - The company reported revenue of $51.2 million for Q3 2024, reflecting a 15% year-over-year growth [10][52] - Adjusted EBITDA for the quarter was $11.1 million, resulting in an adjusted EBITDA margin of 21.8%, which is an increase of over 320 basis points from the same period last year [60] - Annual Recurring Revenue (ARR) reached $202.7 million, up 14% year-over-year, marking the first time it has crossed the $200 million mark [57] - Adjusted gross profit increased by 17% year-over-year to $35.2 million, with an adjusted gross margin of 68.8% [59] Business Line Data and Key Metrics Changes - The company signed 38 new clients in Q3 2024, bringing the total client count to 894 [10] - The average total value (ATV) for the firm rose to $229,000 in Q3, representing a 5.7% year-over-year growth [12] - The front book contributed 14% to revenue growth, while the back book contributed 1% [52] Market Data and Key Metrics Changes - Revenue in the Americas grew 17% year-over-year, significantly up from 10% last year [15] - EMEA revenue grew 22% year-over-year, although it saw a slight decline from the previous quarter due to involuntary churn [23] - Asia-Pacific revenue grew 6% year-over-year, moderating from 10% growth in the previous quarter [28] Company Strategy and Development Direction - The company is focused on executing its long-term strategy by expanding into higher value market segments and enhancing its product offerings [6][8] - There is a strong emphasis on winning new business through product development, particularly the Portfolio Workbench tool, which has been central to attracting larger clients [13][49] - The company is evaluating an expansion of its corporate footprint in Dubai, viewing the region as strategically important [48] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving medium-term guidance of 20% to 22% revenue growth from 2025 to 2027, based on the ability to win new business and expand geographic reach [8][49] - The management acknowledged temporary softness in back book growth but expects it to be offset by product deployments and pricing actions [56] - Conversations with clients indicate a cautious approach due to upcoming elections and interest rate environments, but overall sentiment remains positive [97] Other Important Information - The company ended the quarter with approximately $48 million in cash and cash equivalents and no outstanding debt, providing adequate liquidity for growth objectives [63] - Adjusted free cash flow for the quarter was $13.7 million, with a conversion rate of 123% [61] Q&A Session Summary Question: Thoughts on the state of the business and potential strategic alternatives - Management refrained from commenting on rumors but emphasized a focus on long-term shareholder value [69] Question: Confidence in midterm outlook and pricing actions - Management highlighted new hires and product opportunities as key drivers for confidence in 2025 performance [72][73] Question: Evolution of the executive team and its impact on up-market strategy - New senior hires are expected to enhance the company's ability to capture market opportunities and improve managed services [79] Question: Conversion trends and pipeline trajectory - The company reported a conversion rate of 30% to 40% for qualified opportunities in the up-market space, aided by recent product enhancements [83] Question: Dynamics of ACV growth and underlying drivers - Management noted that ACV can fluctuate and emphasized the importance of monitoring trends over multiple quarters [104]

0 = HOWO TO �� wolford on ono a color of the order of on one on one of one . Enfusion 3Q 2024 T LE CONOMIC CONSULT OF OF TO THE OF TO TO TO TO TO Shareholder Letter · · · · · · · · · · · · · · 000000 0 November 2024 . . - 0 .. . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . t to the submit of the county of the county 000 000 000 - 0.0 . 0 . 0 . 0 . 0 . 0 . 0 . 0 . 0 . 0 . 0 . 0 . . . . . ... ¨·· ënfusion ©2024 ENFUSION. ALL RIGHTS RESERVED. Disclaimer 2 Forward-Looking Statements Statem ...

Enfusion, Inc. (ENFN) came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -16.67%. A quarter ago, it was expected that this company would post earnings of $0.06 per share when it actually produced earnings of $0.05, delivering a surprise of -16.67%.Over the last four quarters, the company ...

Exhibit 99.1 . . . . . To o Top . . . . . ● -- ● ● ● . ······ 000 0 0 � ● ● ● November 2024 o o o o o o o o 0 · 0 · 0 · 0 · 0 ● ● 0 enfusion Enfusion 3Q 2024 . . Shareholder Letter · · · · · 0 0 0 Disclaimer Forward-Looking Statements Statements we make in this presentation may include statements which are not historical facts and are considered forward- looking within the meaning of Section 27A of the Securities Act of 1933 (Securities Act) and Section 21E of the Securities Exchange Act of 1934 (Exchange A ...

Enfusion, Inc. (ENFN) shares rallied 5% in the last trading session to close at $8.98. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 5.3% gain over the past four weeks. Enfusion is benefiting from robust client acquisition and successful expansion into institutional asset management markets. This company is expected to post quarterly earnings of $0.06 per share in its upcoming report, which represents a yea ...